Search - tctmd.com

Displaying 661 - 680 of 1353

Sort: Relevancy | Date

News Daily News

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

Todd Neale

October 12, 2018

News Daily News

Church-Based Lifestyle Intervention Shows Promise for Lowering BP in Hypertensive African-Americans

Todd Neale

October 09, 2018

News Daily News

Prescription Omega-3 Fatty Acids Cut Cardiovascular Events: REDUCE-IT

Shelley Wood

September 24, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

News Daily News

Physical Activity in Short Supply Worldwide, WHO Researchers Find

Caitlin E. Cox

September 12, 2018

News Daily News

Pharmacist-Led BP Telemonitoring Intervention Works Up to 1 Year After Program Stops

Yael L. Maxwell

September 10, 2018

News Daily News

Newly Defined Stage 1 Hypertension Tied to CVD Risk in Younger Chinese Adults

Todd Neale

September 07, 2018

News Daily News

High LDL and Non-HDL Cholesterol Tied to CV Mortality Even in Low-Risk Individuals

Lucy Hicks

August 21, 2018

News Daily News

BMI, Blood Pressure Strongly Linked Across Diverse Subgroups in China

Caitlin E. Cox

August 21, 2018

News Daily News

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Caitlin E. Cox

August 15, 2018

News Daily News

TRIUMPH in Print: Triple-Drug Polypill Shines for Fast, Safe Blood Pressure Reduction

Shelley Wood

August 15, 2018

News Daily News

Aging Data: Study Highlights Delays From Time of Clinical Trial Enrollment to Publication

Yael L. Maxwell

August 15, 2018

News Daily News

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Michael O'Riordan

August 13, 2018

News Daily News

Women Likely Not Good Targets for AAA Screening, Study Suggests

Lucy Hicks

August 13, 2018

$A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years$

News Daily News

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Yael L. Maxwell

August 10, 2018

News Daily News

Valsartan Recall Expanded by FDA and European Medicines Agency

Shelley Wood

August 10, 2018

News Daily News

Faulting Salt? New PURE Analysis Argues Against Low Sodium Intake

Todd Neale

August 10, 2018

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

L.A. McKeown

August 09, 2018

News Daily News

New AHA Advisory Waffles on Artificially Sweetened Drinks, Citing Dearth of Studies

Lucy Hicks

August 07, 2018

News Daily News

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

Yael L. Maxwell

August 03, 2018

Advertisement

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

Church-Based Lifestyle Intervention Shows Promise for Lowering BP in Hypertensive African-Americans

Prescription Omega-3 Fatty Acids Cut Cardiovascular Events: REDUCE-IT

High Mortality but Durable Results With Valve-in-Valve TAVR

Physical Activity in Short Supply Worldwide, WHO Researchers Find

Pharmacist-Led BP Telemonitoring Intervention Works Up to 1 Year After Program Stops

Newly Defined Stage 1 Hypertension Tied to CVD Risk in Younger Chinese Adults

High LDL and Non-HDL Cholesterol Tied to CV Mortality Even in Low-Risk Individuals

BMI, Blood Pressure Strongly Linked Across Diverse Subgroups in China

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

TRIUMPH in Print: Triple-Drug Polypill Shines for Fast, Safe Blood Pressure Reduction

Aging Data: Study Highlights Delays From Time of Clinical Trial Enrollment to Publication

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Women Likely Not Good Targets for AAA Screening, Study Suggests

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Valsartan Recall Expanded by FDA and European Medicines Agency

Faulting Salt? New PURE Analysis Argues Against Low Sodium Intake

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

New AHA Advisory Waffles on Artificially Sweetened Drinks, Citing Dearth of Studies

Elevated High-Sensitivity CRP Lingers Long After MI, Observational Study Shows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content